Notably, PGC-1ɑ functions as an essential regulator for mitochondrial biogenesis and energy metabolism, which plays an important role in the prevention of dyslipidemia and NAFLD [41,42]. This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatotic liver disease.